Medicare Price Negotiation Round Two: New Administration, More Drugs, Less Time

 
• By Cathy Kelly
  
Manufacturers targeted by the price negotiation process have little time to decide whether to participate. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip